Home|Journals|Articles by Year Follow on Twitter| Subscribe to List

Directory for Medical Articles

Open Access

Original Research

Discovery of predictive biomarker candidates for intrinsic resistance to FOLFOX chemotherapy in colon cancer using a Top Down LC-MALDI approach

Florian Tobias Unger, Markus Meyer, Hartmut Juhl, Kerstin Anneliese David.

Chemo resistance of cancer cells to chemotherapeutics is a main obstacle in chemotherapy to a successful outcome especially in first line, but also in later stages of chemotherapy. Chemotherapeutic agents are still the backbone of colorectal cancer therapy, but molecular determinants of chemoresistance are still lacking. The proteome of each cell is responsible for fundamental biological processes and also makes up the bulk of pharmaceutical targets and potential biomarkers. In this study, we used a newly developed top down LC-MALDI-MS-MS workflow to analyze the low molecular weight proteome of chemosensitive and chemoresistant cell lines in order to discover protein biomarker for intrinsic chemoresistance to FOLFOX chemotherapy in colorectal cancer. The discovery of predictive biomarkers for chemoresistance and the identification of molecular mechanisms underlying intrinsic chemoresistance could tremendously promote individualized chemotherapy.

Key words: intrinsic chemoresistance; predictive biomarker; Proteomics; FOLFOX therapy; colorectal cancer

Share this Article

American Journal of Research in Medical Sciences


BiblioMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.